MARKET

DGX

DGX

QuestDiagnostics
NYSE

Real-time Quotes | Nasdaq Last Sale

114.63
-1.11
-0.96%
After Hours: 114.63 0 0.00% 19:45 02/25 EST
OPEN
115.49
PREV CLOSE
115.74
HIGH
116.84
LOW
113.69
VOLUME
1.43M
TURNOVER
--
52 WEEK HIGH
134.71
52 WEEK LOW
73.02
MARKET CAP
15.30B
P/E (TTM)
10.97
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Quest Diagnostics Inc. stock outperforms market despite losses on the day
marketwatch.com · 9h ago
American Kidney Fund Announces 2021 Class of Corporate Members Aligned in Fighting Kidney Disease
February 25, 2021 (ACCESSWIRE via COMTEX) -- ROCKVILLE, MD / ACCESSWIRE / February 25, 2021 / The American Kidney Fund (AKF) today announced the 2021 class...
ACCESSWIRE · 16h ago
Toxicology Drug Screening Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
Feb 25, 2021 (Market Insight Reports) -- The Global Toxicology Drug Screening Market is expected to grow at a CAGR of over 7.1% during the forecast period...
Market Insight Reports · 18h ago
Genalyte and Sonora Quest Laboratories Partner to Provide Predictive Analytics for Cigna's Medicare Advantage Plan
SAN DIEGO, Feb. 25, 2021 /PRNewswire via COMTEX/ -- SAN DIEGO, Feb. 25, 2021 /PRNewswire/ -- Genalyte, a health care diagnostics and analytics company, and...
PR Newswire - PRF · 18h ago
Esoteric Testing Market Research Revealing the Growth Rate and Business Opportunities to 2027
Heraldkeepers · 20h ago
Cancer Biomarkers Market Research Report by Type, by Product, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19
Feb 25, 2021 (Heraldkeepers) -- The scope of the report includes a detailed study of global and regional markets on Global Cancer Biomarkers Market with the...
Heraldkeepers · 20h ago
Preimplantation Genetic Screening Market 2021–Global Industry Analysis, Size, Share, Trends, Demand, Growth, Opportunities and Forecast 2026
Feb 25, 2021 (The Expresswire) -- Global “Preimplantation Genetic Screening Market” (2021-2026) to its vast repository provides important statistics centres...
The Express Wire · 22h ago
Helicobacter Pylori Diagnostics Market Demand, Share, Growth, PESTLE Analysis, Global Industry Overview, 2021-2027 | Thermo Fisher Scientific, Biohit, Quest Diagnostics, Meridian Bioscience, Bio-Rad Laboratories
Market Insight Reports · 22h ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DGX. Analyze the recent business situations of QuestDiagnostics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DGX stock price target is 140.40 with a high estimate of 158.00 and a low estimate of 125.00.
EPS
Institutional Holdings
Institutions: 1.15K
Institutional Holdings: 127.35M
% Owned: 95.42%
Shares Outstanding: 133.45M
TypeInstitutionsShares
Increased
280
7.32M
New
176
-24.10K
Decreased
250
8.37M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-3.27%
Healthcare Providers & Services
-2.20%
Key Executives
Chairman/President/Chief Executive Officer/Director
Stephen Rusckowski
Chief Financial Officer/Executive Vice President
Mark Guinan
Executive Vice President
James Davis
Senior Vice President/General Counsel
Michael Prevoznik
Senior Vice President
Catherine Doherty
Senior Vice President
Carrie Manner
Lead Director/Independent Director
Daniel Stanzione
Independent Director
Vicky Gregg
Independent Director
Wright Lassiter
Independent Director
Timothy Main
Independent Director
Denise Morrison
Independent Director
Gary Pfeiffer
Independent Director
Timothy Ring
Independent Director
Helen Torley
Independent Director
Gail Wilensky
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
02/04/2021
Dividend USD 0.62
04/06/2021
11/18/2020
Dividend USD 0.56
01/19/2021
08/18/2020
Dividend USD 0.56
10/05/2020
05/18/2020
Dividend USD 0.56
07/07/2020
01/30/2020
Dividend USD 0.56
04/06/2020
11/20/2019
Dividend USD 0.53
01/13/2020
08/15/2019
Dividend USD 0.53
10/03/2019
05/14/2019
Dividend USD 0.53
07/05/2019
03/01/2019
Dividend USD 0.53
04/05/2019
11/28/2018
Dividend USD 0.53
01/14/2019
08/17/2018
Dividend USD 0.5
10/04/2018
05/14/2018
Dividend USD 0.5
07/06/2018
02/01/2018
Dividend USD 0.5
04/03/2018
11/29/2017
Dividend USD 0.45
01/08/2018
08/18/2017
Dividend USD 0.45
10/02/2017
05/16/2017
Dividend USD 0.45
07/06/2017
02/21/2017
Dividend USD 0.45
04/03/2017
11/21/2016
Dividend USD 0.45
01/06/2017
08/17/2016
Dividend USD 0.4
09/30/2016
05/18/2016
Dividend USD 0.4
07/01/2016
02/02/2016
Dividend USD 0.4
04/04/2016
12/04/2015
Dividend USD 0.38
01/08/2016
08/18/2015
Dividend USD 0.38
10/02/2015
05/15/2015
Dividend USD 0.38
07/06/2015
01/29/2015
Dividend USD 0.38
04/06/2015
12/04/2014
Dividend USD 0.33
01/09/2015
08/15/2014
Dividend USD 0.33
10/03/2014
05/21/2014
Dividend USD 0.33
07/07/2014
01/30/2014
Dividend USD 0.33
04/04/2014
12/06/2013
Dividend USD 0.3
01/03/2014
08/20/2013
Dividend USD 0.3
09/27/2013
05/21/2013
Dividend USD 0.3
06/28/2013
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Webull offers kinds of Quest Diagnostics Inc stock information, including NYSE:DGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DGX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DGX stock methods without spending real money on the virtual paper trading platform.